Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis.

bladder cancer complications enhanced recovery after surgery immunonutrition infections radical cystectomy

Journal

Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834

Informations de publication

Date de publication:
Historique:
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 12 10 2021
Statut: ppublish

Résumé

Radical cystectomy (RC) is the gold standard treatment for patients with muscle-invasive or refractory non-muscle invasive bladder cancer. It is estimated that approximately 64% and 13% of RC patients experience any complication and major complications, respectively. Specialized immunonutrition (SIM) aims to reduce the rates of complications after RC. We reported surgical complication rates in RC patients who received (SIM group) versus who did not receive (no-SIM group) perioperative SIM. Moreover, we investigated factors associated with complications after RC. This is a retrospective cohort study of 52 patients who underwent RC between April 2016 and December 2017. Overall, 26 (50%) patients received perioperative SIM. We recorded age, gender, Charlson Comorbidity Index (CCI), body mass index (BMI), Malnutrition Universal Screening Tool (MUST) score, unintentional weight loss (UWL), SIM drinks consume, surgical approach, urinary diversion, neoadjuvant chemotherapy (NAC), use of total parenteral nutrition (TPN), final pathology, length of stay (LOS), and complications. SIM was associated with higher rates of documented infections ( SIM is not associated with lower rates of post-operative complications in RC candidates. Moreover, higher rates of documented infections were observed in the SIM group. Patients with post-operative ileus experienced more infections. Age, CCI, NAC, and TPN were not predictive of complications.

Identifiants

pubmed: 34027701
doi: 10.1177/15347354211019483
pmc: PMC8142230
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15347354211019483

Références

J Laparoendosc Adv Surg Tech A. 2012 Jan-Feb;22(1):17-21
pubmed: 22142028
J Urol. 2006 Sep;176(3):945-8; discussion 948-9
pubmed: 16890663
Eur Urol. 2016 Mar;69(3):389-92
pubmed: 26654125
Eur Urol. 2014 Sep;66(3):561-8
pubmed: 24486024
J Urol. 2014 Jul;192(1):50-5
pubmed: 24518775
Clin Nutr. 2017 Jun;36(3):623-650
pubmed: 28385477
Kyobu Geka. 2012 Jul;65(7):559-62
pubmed: 22750832
J Urol. 2018 Aug;200(2):292-301
pubmed: 29518432
Can J Urol. 2014 Jun;21(3):7259-65
pubmed: 24978354
Mutat Res. 2004 Jul 13;551(1-2):29-42
pubmed: 15225579
Prog Urol. 2002 Nov;12(5):891-911
pubmed: 12536913
BJU Int. 2008 Apr;101(8):973-7; discussion 977
pubmed: 18005200
J Urol. 2017 Sep;198(3):511-519
pubmed: 28286066
Int J Clin Pharm. 2015 Apr;37(2):379-86
pubmed: 25666940
Nutrients. 2013 Apr 09;5(4):1186-99
pubmed: 23571650
Clin Nutr. 2012 Feb;31(1):74-7
pubmed: 21875767
Curr Urol Rep. 2018 Oct 18;19(12):98
pubmed: 30338450
Urol Clin North Am. 2018 Feb;45(1):11-17
pubmed: 29169443
Urol Oncol. 2016 May;34(5):235.e17-23
pubmed: 26749464
Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):487-94
pubmed: 19512916
Eur Urol. 2013 Mar;63(3):475-82
pubmed: 22695241
Eur Urol. 2016 Dec;70(6):995-1003
pubmed: 27297680
WMJ. 2014 Feb;113(1):20-3
pubmed: 24712216
Crit Rev Oncol Hematol. 2012 Oct;84(1):26-36
pubmed: 22365185
J Trauma Acute Care Surg. 2012 Oct;73(4):801-8
pubmed: 22976420
Perioper Med (Lond). 2017 Dec 11;6:24
pubmed: 29238571
BJU Int. 2014 Aug;114(2):221-8
pubmed: 24274722
World J Surg. 2006 Aug;30(8):1592-604
pubmed: 16794908
JPEN J Parenter Enteral Nutr. 2014 Jan;38(1):53-69
pubmed: 23411423
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Curr Urol Rep. 2018 Oct 18;19(12):99
pubmed: 30338466
Nat Rev Immunol. 2009 Jan;9(1):57-62
pubmed: 19104499
Can Urol Assoc J. 2011 Oct;5(5):342-8
pubmed: 22031616
BJU Int. 2016 Nov;118(5):714-722
pubmed: 26950039
Eur Urol. 2013 Jul;64(1):52-7
pubmed: 23380164
BJU Int. 2014 Aug;114(2):177-84
pubmed: 24410904
Can J Urol. 2017 Aug;24(4):8895-8901
pubmed: 28832307
World J Urol. 2014 Feb;32(1):233-7
pubmed: 24362882
N Engl J Med. 2003 Aug 28;349(9):859-66
pubmed: 12944571
J Nutr. 2007 Jun;137(6 Suppl 2):1681S-1686S
pubmed: 17513447
J Urol. 1985 Nov;134(5):1032-6
pubmed: 3932677

Auteurs

Gabriele Cozzi (G)

European Institute of Oncology, IRCCS, Milan, Italy.

Gennaro Musi (G)

European Institute of Oncology, IRCCS, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Martina Milani (M)

European Institute of Oncology, IRCCS, Milan, Italy.

Costantino Jemos (C)

European Institute of Oncology, IRCCS, Milan, Italy.

Sara Gandini (S)

European Institute of Oncology, IRCCS, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Ludovica Mazzoleni (L)

Università degli Studi di Pavia, Pavia, Italy.

Matteo Ferro (M)

European Institute of Oncology, IRCCS, Milan, Italy.

Stefano Luzzago (S)

European Institute of Oncology, IRCCS, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Roberto Bianchi (R)

European Institute of Oncology, IRCCS, Milan, Italy.

Emanuela Omodeo Salé (E)

European Institute of Oncology, IRCCS, Milan, Italy.

Ottavio de Cobelli (O)

European Institute of Oncology, IRCCS, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH